China Universal Asset Management Co., Ltd. C4 Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.17 Billion
- Q3 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 12,475 shares of CCCC stock, worth $30,813. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,475
Previous 14,261
12.52%
Holding current value
$30,813
Previous $20,000
35.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CCCC
# of Institutions
108Shares Held
55.5MCall Options Held
329KPut Options Held
186K-
Lynx1 Capital Management LP San Juan, PR7.1MShares$17.5 Million3.06% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.05MShares$17.4 Million0.95% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.24MShares$12.9 Million0.4% of portfolio
-
Morgan Stanley New York, NY4.97MShares$12.3 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT4.85MShares$12 Million0.06% of portfolio
About C4 Therapeutics, Inc.
- Ticker CCCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,913,800
- Market Cap $121M
- Description
- C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...